3/A

FORM 3/A

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: July 23, 2014
Period of Report: May 31, 2012
Accession Number: 0001140361-14-029092

View Document ↗ View on SEC.gov ↗